WHO reports widespread overuse of antibiotics in patients hospitalized with COVID-19

  28 April 2024

The World Health Organization (WHO) has revealed that the overuse of antibiotics during the COVID-19 pandemic may have exacerbated the “silent” spread of antimicrobial resistance (AMR). The study found that 75% of hospitalized COVID-19 patients had bacterial co-infections requiring antibiotics, with the highest rate observed among severe or critical cases. The study found that ‘Watch’ antibiotics with higher resistance potential were most frequently prescribed globally. The findings call for improvements in the rational use of antibiotics to minimize unnecessary negative consequences for patients and populations. The findings are based on data from 40,000 patients admitted to hospitals in 65 countries over a three-year period. The findings are being presented at the ESCMID Global Congress and are relevant to the upcoming UN General Assembly High-Level Meeting on AMR in September.

Further reading: WHO
Author(s): WHO
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed